Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine

INTRODUCTION: Patients with end-stage kidney disease (ESKD) are at risk of severe coronavirus disease and mortality. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inactivated whole-virus vaccine in patients with ESKD has never been explored. METHODS: We conducted a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Boongird, Sarinya, Chuengsaman, Piyatida, Setthaudom, Chavachol, Nongnuch, Arkom, Assanatham, Montira, Phanprasert, Salinnart, Kitpermkiat, Rungthiwa, Kiertiburanakul, Sasisopin, Malathum, Kumthorn, Phuphuakrat, Angsana, Davenport, Andrew, Bruminhent, Jackrapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639296/
https://www.ncbi.nlm.nih.gov/pubmed/34859359
http://dx.doi.org/10.1007/s40121-021-00574-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639296/
https://www.ncbi.nlm.nih.gov/pubmed/34859359
http://dx.doi.org/10.1007/s40121-021-00574-9

Ejemplares similares